TITLE

Number of A� Inoculations in APP+PS1 Transgenic Mice Influences Antibody Titers, Microglial Activation, and Congophilic Plaque Levels

AUTHOR(S)
Wilcock, Donna M.; Gordon, Marcia N.; Ugen, Kenneth E.; Gottschall, Paul E.; DiCarlo, Giovanni; Dickey, Chad; Boyett, Kristal W.; Jantzen, Paul T.; Connor, Karen E.; Melachrino, Jason; Hardy, John; Morgan, David
PUB. DATE
November 2001
SOURCE
DNA & Cell Biology;Nov2001, Vol. 20 Issue 11, p731
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
There have been several reports on the use of �-amyloid (A� ) vaccination in different mouse models of Alzheimer's disease (AD) and its effects on pathology and cognitive function. In this report, the histopathologic findings in the APP+PS1 doubly transgenic mouse were compared after three, five, or nine A� inoculations. The number of inoculations influenced the effects of vaccination on Congo red levels, microglia activation, and anti-A� antibody titers. After three inoculations, the antibody titer of transgenic mice was substantially lower than that found in nontransgenic animals. However, after nine inoculations, the levels were considerably higher in both genotypes and no longer distinguishable statistically. The number of inoculations influenced CD45 expression, an indicator of microglial activation. There was an initial upregulation, which was significant after five inoculations, but by nine inoculations, the extent of microglial activation was equivalent to that in mice given control vaccinations. Along with this increased CD45 expression, there was a correlative reduction in staining by Congo red, which stains compact plaques. When data from the mice from all groups were combined, there was a significant correlation between activation of microglia and Congo red levels, suggesting that microglia play a role in the clearance of compact plaque.
ACCESSION #
5849362

 

Related Articles

  • Origin and turnover of microglial cells in fibrillar plaques of APPsw transgenic mice. Wegiel, Jerzy; Imaki, Humi; Wang, Kuo-Chiang; Wegiel, Jarek; Wronska, Anetta; Osuchowski, Marcin; Rubenstein, Richard // Acta Neuropathologica;Apr2003, Vol. 105 Issue 4, p393 

    Activated microglial cells are an integral component of fibrillar plaques in brains of subjects with Alzheimer's disease (AD) and in brains of transgenic mice overexpressing amyloidogenic fragments of human amyloid precursor protein (APP). The aim of this ultrastructural study of fibrillar...

  • Optimized Turmeric Extract Reduces β-Amyloid and Phosphorylated Tau Protein Burden in Alzheimer's Transgenic Mice. Douglas Shytle, R.; Tan, Jun; C. Bickford, Paula; Rezai-zadeh, Kavon; Hou, L; Zeng, Jin; R. Sanberg, Paul; D. Sanberg, Cyndy; S. Alberte, Randall; C. Fink, Ryan; Roschek Jr, Bill // Current Alzheimer Research;May2012, Vol. 9 Issue 4, p500 

    In a previous in vitro study, the standardized turmeric extract, HSS-888, showed strong inhibition of Aβ aggregation and secretion in vitro, indicating that HSS-888 might be therapeutically important. Therefore, in the present study, HSS-888 was evaluated in vivo using transgenic 'Alzheimer'...

  • Intracranial administration of deglycosylated C-terminal-specific anti-Aβ antibody efficiently clears amyloid plaques without activating microglia in amyloid-depositing transgenic mice. Carty, Niki C.; Wilcock, Donna M.; Rosenthal, Arnon; Grimm, Jan; Pons, Jaume; Ronan, Victoria; Gottschall, Paul E.; Gordon, Marcia N.; Morgan, Dave // Journal of Neuroinflammation;2006, Vol. 3, p11 

    Background: Antibodies against the Aβ peptide clear Aβ deposits when injected intracranially. Deglycosylated antibodies have reduced effector functions compared to their intact counterparts, potentially avoiding immune activation. Methods: Deglycosylated or intact C-terminal specific high...

  • The absence of myelin basic protein promotes neuroinflammation and reduces amyloid beta-protein accumulation in Tg-5xFAD mice. Ou-Yang, Ming-Hsuan; Van Nostrand, William E. // Journal of Neuroinflammation;2013, Vol. 10 Issue 1, p1 

    Background Abnormal accumulation of amyloid β-protein (Aβ) in the brain plays an important role in the pathogenesis of Alzheimer's disease (AD). Aβ monomers assemble into oligomers and fibrils that promote neuronal dysfunction. This assembly pathway is influenced by naturally occurring...

  • APP Transgenic Mouse Models and their Use in Drug Discovery to Evaluate Amyloid-� Lowering Therapeutics. Hussain, Ishrut // CNS & Neurological Disorders - Drug Targets;Aug2010, Vol. 9 Issue 4, p395 

    A critical requirement in the development of Alzheimer's disease (AD) therapeutics is a demonstration of the in vivo efficacy of compounds in pre-clinical disease relevant models. One of the most frequently used models in AD research are transgenic mice overexpressing mutant forms of human...

  • Activation of microglial cells by beta-amyloid protein and interferon-gamma. Meda, Lucia; Cassatella, Marco A. // Nature;4/13/1995, Vol. 374 Issue 6523, p647 

    Describes the synergistic effect between aggregates of beta-amyloid protein and interferon-gamma in triggering the production of reactive nitrogen intermediates and tumor-necrosis factor-alpha from microglia. Result of the activation of microglia with interferon-gamma and the aggregates of...

  • Scavengers suspected in Alzheimer's. Spinney, Laura // New Scientist;10/19/96, Vol. 152 Issue 2052, p21 

    Cites a study indicating that Alzheimer's disease is caused by the failure of microglia to remove beta-amyloid protein from the brain. Blocking the uptake of beta-amyloid; Scavenger receptors of microglia in Alzheimer's patients.

  • Behavioral Assessment of Alzheimer's Transgenic Mice Following Long-Term A� Vaccination: Task Specificity and Correlations between A� Deposition and Spatial Memory. Arendash, Gary W.; Gordon, Marcia N.; Diamond, David M.; Austin, Leigh Ann; Hatcher, Jaime M.; Jantzen, Paul; DiCarlo, Giovanni; Wilcock, Donna; Morgan, Dave // DNA & Cell Biology;Nov2001, Vol. 20 Issue 11, p737 

    Long-term vaccinations with human �-amyloid peptide 1-42 (A�1-42) have recently been shown to prevent or markedly reduce A� deposition in the PDAPP transgenic model of Alzheimer's disease (AD). Using a similar protocol to vaccinate 7.5-month-old APP (Tg2576) and APP+PS1 transgenic...

  • Extracellular amyloid formation and associated pathology in neural grafts. Meyer-Luehmann, Melanie; Stalder, Martina; Herzig, Martin C.; Kaeser, Stephan A.; Kohler, Esther; Pfeifer, Michelle; Boncristiano, Sonia; Mathews, Paul M.; Mercken, Marc; Abramowski, Dorothee; Staufenbiel, Matthias; Jucker, Mathias // Nature Neuroscience;Apr2003, Vol. 6 Issue 4, p370 

    Amyloid precursor protein (APP) processing and the generation of �-amyloid peptide (A�) are important in the pathogenesis of Alzheimer's disease. Although this has been studied extensively at the molecular and cellular levels, much less is known about the mechanisms of amyloid...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics